Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!

Coronavirus pandemic | Swiggy establishes COVID-19 relief fund for delivery partners, their families

The corpus for the fund will be created by Swiggy with primary contributions from the founders, senior leaders, employees and investors, as well as donations from customers and well-wishers

March 31, 2020 / 08:50 PM IST

Food ordering and delivery platform Swiggy on Tuesday said it has set up a relief fund called 'Swiggy Hunger Savior Covid Relief Fund' for the safety and welfare of its delivery partners and their families.

The corpus for the fund will be created by Swiggy with primary contributions from the founders, senior leaders, employees and investors, as well as donations from customers and well-wishers, Swiggy said in a statement.

As a start, Swiggy Chief Executive Officer Sriharsha Majety has committed 50 per cent of his annual salary towards this fund, it added.

The company aims to raise Rs 10 crore for this fund and has already raised over 4 crore through initial contributions from Swiggy, its founders and employees, Swiggy said.

"To assist our delivery heroes during these testing times, we have initiated this special fund which will be supported by Swiggy and our investors. I am overwhelmed by this collective initiative to support one another while also doing what we do best, which is serving customers," Majety said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Through the fund, delivery partners are now covered with Income-Protection Insurance where up to 14 days of income is insured if tested positive with COVID-19, the statement said.

The fund will also be used to provide sustenance support through food and grocery care packages to the partners and their families who are facing hardships, it added.
PTI

stay updated

Get Daily News on your Browser
Sections